TACSTD2 and neoplasm: Cases that showed an increased (Bd2) or even high level (Bd3) of tumour budding according to the ITBCC scoring system showed a much higher frequency of TROP2 positivity than carcinomas with no or low tumour budding (Bd1, p < 0.001).